Here's Why GreenWood Invested in MEI Pharma (MEIP)
GreenWood Investors LLC, an investment management firm, released its second quarter 2022 investor letter. A copy of the same can be downloaded here.
Mei Pharma Inc. (MEIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Laurion Capital Management Benjamin A. Smith | 2,576,900 | $627,733 | 0% | |
| 2. | Carlson Capital Clint Carlson | 1,180,000 | $287,448 | +3% | 0.02% |
| 3. | 76,700 | $18,684 | +140% | 0% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 13,000 | $3,167 | -64% | 0% |
| 5. | 5,100 | $1,242 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.23 | 81,500 | Director | 105,750 | 2023-02-28 | Filing | |
| $1.60 | 10,000 | Director | 10,000 | 2019-12-19 | Filing | |
| $1.60 | 62,500 | Director | 62,500 | 2019-12-19 | Filing | |
| $1.60 | 12,500 | Officer | 37,500 | 2019-12-19 | Filing | |
| $1.60 | 18,750 | Officer, Director | 361,632 | 2019-12-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.03 | 25,000 | Director | 37,500 | 2021-02-23 | Filing | |
| $3.58 | 9,500 | Officer | 24,106 | 2018-08-07 | Filing | |
| $2.21 | 11,000 | Director | 13,250 | 2017-11-27 | Filing | |
| $1.75 | 157,352 | Large Shareholder | 3,163,105 | 2015-11-09 | Filing | |
| $1.85 | 7,560 | Large Shareholder | 3,320,457 | 2015-11-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 10,617,959 | $2,586,535 | 0.42% | |
| 2. | 8,533,072 | $2,078,656 | 0.11% | |
| 3. | 7,671,024 | $1,868,661 | 0% | |
| 4. | 2,913,091 | $709,629 | 0.03% | |
| 5. | 1,545,105 | $376,388 | 0% |
News See All
MEI Pharma Inc (MEIP): Are Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is MEIP A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Top 5 Healthcare Stocks for the Future
Below we present the list of Top 5 Healthcare Stocks for the Future. For the first half of the list and an introduction to Dr.
Hedge Funds Have Never Been This Bullish On MEI Pharma Inc (MEIP)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Souring On MEI Pharma Inc (MEIP)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
MEI Pharma Inc (NASDAQ:MEIP): Hedge Funds In Wait-and-See Mode
Does MEI Pharma Inc (NASDAQ:MEIP) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
Is MEI Pharma Inc (MEIP) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Lay Out Bullish Cases for Tyson Foods, Credit Acceptance Corp, and More
Given that the third quarter is in the rear view mirror, a number of elite funds have released their latest investor letters.
Billionaire Hedge Funds
